Prescription psychedelics: The road from FDA approval to clinical practice

This free full-text article comments "After languishing for decades from legal restrictions and stigma, research into psychedelic drugs is exploding – with the encouragement of the Food and Drug Administration. Recent clinical trial successes suggest some long-banned drugs could soon be authorized as treatments for debilitating illnesses. Yet because of these drugs’ history, FDA approval would be just one important step in a complex process to transform these compounds into therapies. Incorporating psychedelic drugs into clinical practice will require peeling back multiple layers of legal prohibition, clarifying prescribing guidelines, and developing treatment models that work for drug-makers, physicians, and payers."

For more psychedelic news and research, visit the psychedelic health professional network homepage.

Previous
Previous

Ayahuasca may help to improve self-compassion and self-criticism capacities

Next
Next

Sub-acute and long-term effects of ayahuasca on mental health and well-being in healthy ceremony attendants: A replication study